首页> 外文期刊>Bulletin of experimental biology and medicine >Involvement of HLDF protein and anti-HLDF antibodies in the mechanisms of blood pressure regulation in healthy individuals and patients with stable hypertension and hypertensive crisis
【24h】

Involvement of HLDF protein and anti-HLDF antibodies in the mechanisms of blood pressure regulation in healthy individuals and patients with stable hypertension and hypertensive crisis

机译:HLDF蛋白和抗HLDF抗体参与健康个体和稳定高血压和高血压危机患者的血压调节机制

获取原文
获取原文并翻译 | 示例
           

摘要

We studied the relationships between the blood serum levels of human leukemia differentiation factor HLDF, idiotypic and anti-idiotypic antibodies to HLDF, and clinical indicators of cardiovascular function in apparently healthy individuals and patients with essential hypertension and cerebral hypertensive crisis. Markedly reduced HLDF levels and anti-HLDF antibody titers were found in the blood of the examined patients. Correlations between HLDF levels, duration of hypertension, and systolic and diastolic BP were revealed. These findings suggest that the studied molecular factors are involved in the mechanisms of BP regulation under normal conditions and during hypertension development. The protein HLDF and anti-HLDF antibodies can be considered as biomarkers for early diagnosis of hypertension and its cerebral complications.
机译:我们研究了人类白血病分化因子HLDF的血清水平,针对HLDF的独特型和抗独特型抗体与明显健康的个体以及患有原发性高血压和脑高血压危机的患者的心血管功能临床指标之间的关系。在检查的患者血液中发现HLDF水平显着降低,抗HLDF抗体滴度降低。揭示了HLDF水平,高血压持续时间与收缩压和舒张压之间的相关性。这些发现表明,所研究的分子因素在正常条件下和高血压发展过程中参与了BP调节的机制。 HLDF和抗HLDF蛋白抗体可被视为早期诊断高血压及其脑并发症的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号